Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Ancuta, Petronela ^a,g   Kamat, Anupa ^a   Kunstman, Kevin J ^b   Kim, Eun Young ^b   Autissier, Patrick ^c   Wurcel, Alysse ^d   Zaman, Tauheed ^d   Stone, David ^d   Mefford, Megan ^a   Morgello, Susan ^e   Singer, Elyse J ^f   Wolinsky, Steven M ^b   Gabuzda, Dana ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d LEMUEL SHATTUCK HOSPITAL   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f UCLA MEDICAL CENTER   (United States)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD69 ANTIGEN; DIAMORPHINE; ENDOTOXIN ANTIBODY; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ISOLATION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE TRANSLOCATION; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMULUS LYSATE TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MONOCYTE; PATHOGENESIS; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANCE ABUSE; VIRUS LOAD; BLOOD; CELL SEPARATION; FLOW CYTOMETRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS REPLICATION;

HEPATITIS C VIRUS; LIMULUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS REPLICATION;

EID: 49649129676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002516     Document Type: Article

References (64)

1. Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7: 235-239.
2. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ (2006) Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12: 289-295.
3. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
4. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M (2003) Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9: 101-107.
5. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25: 3418-3424.
6. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
7. Gartner S (2000) HIV infection and dementia. Science 287: 602-604.
8. Ziegler-Heitbrock HW (1996) Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 17: 424-428.
9. Grage-Griebenow E, Flad HD, Ernst M (2001) Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 69: 11-20.
10. Amirayan-Chevillard N, Tissot-Dupont H, Capo C, Brunet C, Dignat-George F, et al. (2000) Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol 120: 107-112.
11. Triques K, Stevenson M (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 78: 5523-5527.
12. Almodovar S, Del CCM, Maldonado IM, Villafane R, Abreu S, et al. (2007) HIV-1 infection of monocytes is directly related to the success of HAART. Virology 369: 35-46.
13. Zhu T, Muthui D, Holte S, Nickle D, Feng F, et al. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14+ monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 76: 707-716.
14. Crowe S, Zhu T, Muller WA (2003) The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 21: 21.
15. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, et al. (2005) Circulating proviral HIV DNA and HIV-associated dementia. Aids 19: 45-52.
16. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178: 6581-6589.
17. Ancuta P, Kunstman KJ, Autissier P, Zaman T, Stone D, et al. (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344: 267-276.
18. Ancuta P, Autissier P, Wurcel A, Zaman T, Stone D, et al. (2006) CD16+ Monocyte-Derived Macrophages Activate Resting T Cells for HIV Infection by Producing CCR3 and CCR4 Ligands. J Immunol 176: 5760-5771.
19. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, et al. (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9: 205-221.
20. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
21. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
22. Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, et al. (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 115: 2534-2545.
23. McArthur JC (2004) HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
24. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, et al. (2007) Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol 13: 23-28.
25. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197: 1701-1707.
26. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98.
27. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, et al. (2001) Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 75: 10073-10089.
28. Ancuta P, Wang J, Gabuzda D (2006) CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 80: 1156-1164.
29. Kapadia F, Vlahov D, Donahoe RM, Friedland G (2005) The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis 41: 1027-1034.
30. Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16: 209-219.
31. Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, et al. (2002) The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res 8: 319-327.
32. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, et al. (2007) Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133: 1627-1636.
33. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, et al. (2007) Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 196: 361-370.
34. Parsons TD, Tucker KA, Hall CD, Robertson WT, Eron JJ, et al. (2006) Neurocognitive functioning and HAART in HIV and hepatitis C virus coinfection. Aids 20: 1591-1595.
35. Morgello S (2005) The nervous system and hepatitis C virus. Semin Liver Dis 25: 118-121.
36. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, et al. (2003) Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37: 208-217.
37. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, et al. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180: 1584-1589.
38. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, et al. (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. Aids 21: 1915-1921.
39. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759.
40. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
41. Cohen IR, Norins LC (1966) Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science 152: 1257-1259.
42. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, et al. (2006) Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108: 1580-1587.
43. Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, et al. (2004) Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 200: 587-599.
44. Van Marle G, Rourke SB, Zhang K, Silva C, Ethier J, et al. (2002) HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain. Aids 16: 1905-1914.
45. Ferrier L, Berard F, Debrauwer L, Chabo C, Langella P, et al. (2006) Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans Thiopentone pharmacokinetics in patients with chronic alcoholism. Am J Pathol 168: 1148-1154.
46. Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, et al. (2002) Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des 8: 995-1005.
47. Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, et al. (2001) Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167: 3677-3681.
48. Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, et al. (2006) Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 163: 412-420.
49. Hutchinson SJ, Brettle RP, Gore SM (1997) Predicting survival in AIDS: refining the model. Qjm 90: 685-692.
50. Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, et al. (1998) Variable progression of HIV-associated dementia. Neurology 50: 1814-1820.
51. Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, et al. (2005) Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol 11: 265-273.
52. Davidson DJ, Currie AJ, Bowdish DM, Brown KL, Rosenberger CM, et al. (2006) IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and nonmyeloid cells. J Immunol 177: 8202-8211.
53. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
54. Chapoval AI, Kamdar SJ, Kremlev SG, Evans R (1998) CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of gram-negative infections. J Leukoc Biol 63: 245-252.
55. Asakura E, Yamauchi T, Umemura A, Hanamura T, Tanabe T (1997) Intravenously administered macrophage colony-stimulating factor (M-CSF) specifically acts on the spleen, resulting in the increasing and activating spleen macrophages for cytokine production in mice. Immunopharmacology 37: 7-14.
56. Rankine EL, Hughes PM, Botham MS, Perry VH, Felton LM (2006) Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci 24: 77-86.
57. Kusdra L, McGuire D, Pulliam L (2002) Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. Aids 16: 31-38.
58. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, et al. (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 99: 13795-13800.
59. Gartner S, Liu Y (2002) Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol 8: 69-75.
60. Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, et al. (2001) Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184: 699-706.
61. Lien E, Aukrust P, Sundan A, Muller F, Froland SS, et al. (1998) Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92: 2084-2092.
62. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P (2006) A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol 177: 8103-8110.
63. Xaio H, Banks WA, Niehoff ML, Morley JE (2001) Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res 896: 36-42.
64. Shen Y, Rudnik J, Cassol S, Drouin J, Cameron W, et al. (1994) Blood monocytes from most human immunodeficiency virus type 1-infected patients do not carry proviral DNA. Clin Diagn Lab Immunol 1: 531-537.